Clinical and research uses of genetic risk scores in type 1 diabetes.

2.50
Hdl Handle:
http://hdl.handle.net/11287/620716
Title:
Clinical and research uses of genetic risk scores in type 1 diabetes.
Authors:
Sharp, S. A.; Weedon, M. N.; Hagopian, W. A.; Oram, Richard A.
Abstract:
Type 1 diabetes (T1D) is a chronic disease of high blood glucose caused by autoimmune destruction of pancreatic beta cells eventually resulting in severe insulin deficiency. T1D has a significant heritable risk. Genetic associations found are particularly strong in the HLA class II region but T1D is a polygenic disease associated with over 60 loci across the genome. Polygenic risk scores are one method of summing these genetic risk elements as a single continuous variable. This review discusses the clinical and research utility of genetic risk scores in T1D particularly in disease prediction and progression. We also explore creative uses of genetic risk scores in big data and the limitations of using a genetic risk score. The increase in publically available genetic data and rapid fall in costs of genotyping mean that a T1D genetic risk score (T1D GRS) is likely to prove useful for disease prediction, discrimination, investigation of unusual cohorts, and investigation of biology in large datasets where genetic data are available.
Citation:
Clinical and research uses of genetic risk scores in type 1 diabetes. 2018, 50:96-102 Curr. Opin. Genet. Dev.
Publisher:
Elsevier
Journal:
Current opinion in genetics & development
Issue Date:
24-Apr-2018
URI:
http://hdl.handle.net/11287/620716
DOI:
10.1016/j.gde.2018.03.009
PubMed ID:
29702327
Additional Links:
https://linkinghub.elsevier.com/retrieve/pii/S0959-437X(17)30177-6
Type:
Journal Article
Language:
en
ISSN:
1879-0380
Appears in Collections:
Exeter Kidney Unit (Renal); 2018 RD&E publications

Full metadata record

DC FieldValue Language
dc.contributor.authorSharp, S. A.en
dc.contributor.authorWeedon, M. N.en
dc.contributor.authorHagopian, W. A.en
dc.contributor.authorOram, Richard A.en
dc.date.accessioned2018-06-20T15:44:38Z-
dc.date.available2018-06-20T15:44:38Z-
dc.date.issued2018-04-24-
dc.identifier.citationClinical and research uses of genetic risk scores in type 1 diabetes. 2018, 50:96-102 Curr. Opin. Genet. Dev.en
dc.identifier.issn1879-0380-
dc.identifier.pmid29702327-
dc.identifier.doi10.1016/j.gde.2018.03.009-
dc.identifier.urihttp://hdl.handle.net/11287/620716-
dc.description.abstractType 1 diabetes (T1D) is a chronic disease of high blood glucose caused by autoimmune destruction of pancreatic beta cells eventually resulting in severe insulin deficiency. T1D has a significant heritable risk. Genetic associations found are particularly strong in the HLA class II region but T1D is a polygenic disease associated with over 60 loci across the genome. Polygenic risk scores are one method of summing these genetic risk elements as a single continuous variable. This review discusses the clinical and research utility of genetic risk scores in T1D particularly in disease prediction and progression. We also explore creative uses of genetic risk scores in big data and the limitations of using a genetic risk score. The increase in publically available genetic data and rapid fall in costs of genotyping mean that a T1D genetic risk score (T1D GRS) is likely to prove useful for disease prediction, discrimination, investigation of unusual cohorts, and investigation of biology in large datasets where genetic data are available.en
dc.language.isoenen
dc.publisherElsevieren
dc.relation.urlhttps://linkinghub.elsevier.com/retrieve/pii/S0959-437X(17)30177-6en
dc.rightsArchived with thanks to Current opinion in genetics & developmenten
dc.subjectWessex Classification Subject Headings::Oncology. Pathology.::Geneticsen
dc.titleClinical and research uses of genetic risk scores in type 1 diabetes.en
dc.typeJournal Articleen
dc.identifier.journalCurrent opinion in genetics & developmenten
dc.type.versionPublisheden

Related articles on PubMed

All Items in RD&E Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.